RBC Life Sciences, Inc manufactures, markets, and distributes nutritional supplements and personal care products in North America, Southeast Asia, and Australia. The company's Nutritional Products ...

RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Edwards Lifesciences (EW – Research Report) on January 6 and set a price ...

RBC Capital raised the firm’s price target on Edwards Lifesciences (EW) to $80 from $75 and keeps an Outperform rating on the shares. The firm expects Edwards to discuss its product and clinical ...

97.4% of Vestis shares are held by institutional investors. 45.8% of RBC Life Sciences shares are held by company insiders. Strong institutional ownership is an indication that large money ...